№3 / 2017

A. Guekht, I. Skoog, S. Edmundson, V. Zakharov, A.D. Korczyn
ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin). A randomized controlled trial to assess the efficacy of actovegin in poststroke cognitive impairment
4-15
W. Brinjikji, A.E.-R. El-Masri, J.T. Wald, G. Lanzino
Prevalence of developmental venous anomalies increases with age
16-18
N.I. Khan, F.M. Siddiqui, J.N. Goldstein, M. Cox, Y. Xian, R.A. Matsouaka, P.A. Heidenreich, E.D. Peterson, D.L. Bhatt, G.C. Fonarow, L.H. Schwamm, E.E. Smith
Association between previous use of antiplatelet therapy and intracerebral hemorrhage outcomes
19-27
J.W. van Dalen, E.P. Moll van Charante, M.W.A. Caan, P. Scheltens, C.B.L.M. Majoie, A.J. Nederveen, W.A. van Gool, E. Richard
Effect of long-term vascular care on progression of cerebrovascular lesions. Magnetic resonance imaging substudy of the PreDIVA trial (Prevention of Dementia by Intensive Vascular Care)
28-36
K. Shono, J. Satomi, Y. Tada, Y. Kanematsu, N. Yamamoto, Y. Izumi, R. Kaji, M. Harada, S. Nagahiro
Optimal timing of diffusion-weighted imaging to avoid false-negative findings in patients with transient ischemic attack
37-39
W. Brinjikji, A.M. Demchuk, M.H. Murad, A.A. Rabinstein, R.J. McDonald, J.S. McDonald, D.F. Kallmes
Neurons over nephrons. Systematic review and meta-analysis of contrast-induced nephropathy in patients with acute stroke
40-47
G. Tsivgoulis, A. Safouris
Intravenous thrombolysis in acute ischemic stroke patients pretreated with non-vitamin K antagonist oral anticoagulants
48-51
J.-H. Hong, S.-I. Sohn, J. Kwak, J. Yoo, H.W. Chang, O-K. Kwon, C. Jung, I. Chung, H.-J. Bae, J.S. Lee, M.-K. Han
Dose-dependent effect of statin pretreatment on preventing the periprocedural complications of carotid artery stenting
52-57
D.T. Bundy, L. Souders, K. Baranyai, L. Leonard, G. Schalk, R. Coker, D.W. Moran, T. Huskey, E.C. Leuthardt
Contralesional brain-computer interface control of a powered exoskeleton for motor recovery in chronic stroke survivors
58-65
U. Neuberger, M.A. Möhlenbruch, C. Herweh, C. Ulfert, M. Bendszus, О.J. Pfaff
Classification of bleeding events. Comparison of ECASS III (European Cooperative Acute Stroke Study) and the New Heidelberg bleeding classification
66-69
I. Bravo-Ferrer, M.I. Cuartero, J.G. Zarruk, J.M. Pradillo, O. Hurtado, V.G. Romera, J. Díaz-Alonso, J.M. García-Segura, M. Guzmán, I. Lizasoain, I. Galve-Roperh, M.A. Moro
Cannabinoid type-2 receptor drives neurogenesis and improves functional outcome after stroke
70-76
C.S. Anderson, M.H. Selim, C.A. Molina, A.I. Qureshi
Intensive blood pressure lowering in intracerebral hemorrhage
77-80
H.J.A. van Os, I.A. Mulder, A. Broersen, A. Algra, I.C. van der Schaaf, L.J. Kappelle, B.K. Velthuis, G.M. Terwindt, W.J. Schonewille, M.C. Visser, M.D. Ferrari, M.A.A. van Walderveen, M.J.H. Wermer
Migraine and cerebrovascular atherosclerosis in patients with ischemic stroke
81-84
M.R. Reynolds, G. Lanzino, G.J. Zipfel
Intracranial dural arteriovenous fistulae
85-93

Бионика Медиа